Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1717027

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they plan to support NHS England’s pilot to reduce the faecal immunochemical test threshold for the Bowel Cancer Screening Programme from 120µg/g to 80µg/g; and whether they have had discussions with NHS England regarding geographical areas for the pilot.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4533
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are committed to improving the NHS Bowel Screening programme, and welcome NHS England’s plans for pilot areas, which will reduce the faecal immunochemical test (FIT) down to 80µg/g. NHS England plans to publish an Expression of Interest to give all bowel screening services, and their partner symptomatic endoscopy providers, an opportunity to submit their interest in becoming a FIT@80 pilot site. These pilot sites are planned to be selected and launched later in 2024/25, and attention will be paid to ensure there is regional variation across the pilot sites selected.</p> answering member printed Lord Markham question first answered 20/05/2024 15:13:03 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1713998

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government which groups have a lower-than-average rate of participation in home-kit bowel cancer screening; and what plans they have to increase participation.
tabling member printed	Baroness Merron
uin	HL4105
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>The national IT system for the NHS Bowel Cancer Screening Programme does not routinely collect data that could identify groups that have a lower-than-average uptake rate of the fecal immunochemical bowel cancer screening test.</p><p>Research has found that groups which are less likely to take part in bowel screening include men, people from ethnic minority backgrounds, and people in more deprived areas. Physical or mental health conditions can also make carrying out a home test more difficult.</p><p>NHS England has started work to improve its national screening IT systems through the Digital Transformation of Screening programme. This will enable screening providers to record protected characteristics, to more accurately identify groups with the lowest uptake, and target initiatives to improve uptake.</p> answering member printed Lord Markham question first answered 01/05/2024 14:23:51 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1700141

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve genomics testing for bowel cancer patients.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	20972
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>A National Health Service testing programme is helping to diagnose thousands of people with a genetic condition, Lynch Syndrome, that increases the chance of developing certain cancers including bowel cancer. The national programme ensures all people diagnosed with bowel cancer are offered genomic testing, with a diagnosis for Lynch Syndrome not only helping to guide more personalised cancer treatment but enabling their families and relatives to be offered testing too. Relatives who receive a diagnosis of Lynch Syndrome can be referred to genetic services to discuss regular testing options to help catch any cancers as early as possible, as well as to consider preventive options such as taking aspirin or undergoing risk-reducing surgery.</p><p>Genomic testing in the NHS in England is provided through the NHS Genomic Medicine Service (GMS) and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the National Genomic Test Directory (NGTD) which outlines the full range of genomic testing offered by the NHS in England including tests for 3,200 rare diseases and over 200 cancer clinical indications, including both whole genome sequencing (WGS) and non-WGS testing. The NGTD sets out the eligibility criteria for patients to access testing as well as the genomic targets to be tested and the method that should be used, including testing for bowel cancer patients.</p><p>The NHS GMS cancer genomic testing strategy has facilitated a move to a consolidated laboratory network through the seven NHS GLHs delivering more extensive panel testing using cutting edge high throughput Next Generation Sequencing (NGS) technology. For patients, including those with bowel cancer, this technology enables testing for a larger number of genetic variations to give a more precise diagnosis, identify biomarkers to target treatment and opportunities to access innovative medicines, and can support enrolment into molecularly stratified clinical trials.</p><p>Testing is available for all eligible patients across the whole of England. Individuals should discuss with their healthcare professional (for example, their general practitioner or other healthcare professional if they are already being seen in a relevant service) whether genomic testing is appropriate for them. Their healthcare professional will then make a decision whether to refer the individual either directly or via an NHS clinical genomics service or other relevant clinical speciality for genomic testing following clinical review of their and their family’s medical history if known, and the relevant genomic testing eligibility criteria.</p><p>The 17 NHS Clinical Genomic Services (NHS CGSs), commissioned by NHS England, deliver a comprehensive clinical genomic and counselling service that directs the diagnosis, risk assessment and lifelong clinical management of patients of all ages and their families who have, or are at risk of having, a rare genetic or genomic condition. As part of the NHS CGS, the patient and their family will access diagnosis, and management relevant to their particular condition, but also receive support and guidance so that they are able to understand their condition, its implications, and their options in relation to reproduction, screening, prevention and clinical management.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/04/2024 13:43:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3960 label Biography information for Henry Smith

1690797

registered interest
date	21/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the impact of the decision to lower the age for bowel cancer screening on levels of bowel cancer.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	15027
answer	answer is ministerial correction date of answer 26/02/2024 answer text <p>Evidence shows that screening people at a younger age would enable more bowel cancers to be picked up at an earlier stage, where treatment is likely to be more effective and survival chances improved. Based on the UK National Screening Committee’s (UK NSC) last review of the bowel cancer screening programme, since April 2021, the National Health Service in England has been gradually reducing the age for bowel screening from 60 years old down to 50 years old.</p><p> </p><p>Modelling work commissioned by the UK NSC at the time concluded that introducing the faecal immunochemical test (FIT) for home testing in the 50 to 74 year old age range, at as low a threshold as possible, would be the most cost effective approach. Work continues in this area to ensure that lowering the age of bowel cancer screening down to 50 years old is done with workforce planning and capacity. Further details of the evidence around screening at a younger age and the modelling work, is available at the following link:</p><p><a href="https://view-health-screening-recommendations.service.gov.uk/bowel-cancer/" target="_blank">https://view-health-screening-recommendations.service.gov.uk/bowel-cancer/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/02/2024 10:11:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1689323

registered interest
date	16/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many tests for lynch syndrome were funded by NHS England in 2022.
tabling member constituency	Coventry North West
tabling member printed	Taiwo Owatemi
uin	14243
answer	answer is ministerial correction date of answer 22/02/2024 answer text <p>There are several different stages to testing for Lynch syndrome. We know from local audit data that, in line with the National Institute for Health and Care Excellence’s (NICE) guidelines, the mean proportion of colorectal cancer patients who receive an initial tumour test, immunohistochemistry or microsatellite instability, for Lynch syndrome is 94%, and for endometrial cancer is 95%. Although some funding has been provided to Cancer Alliances by NHS England to support this testing, we do not hold records of the number of tests carried out nationally.</p><p> </p><p>Where the result of the initial tumour test indicates Lynch syndrome, patients are referred for germline testing, which is commissioned directly by NHS England. Testing of family members of Lynch syndrome patients is not a direct Cancer Alliance responsibility. The 17 NHS Clinical Genetics Services are commissioned to provide predictive testing for family members when a diagnosis of Lynch Syndrome has been made in a first degree relative, in accordance with NICE guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 14244 question first answered 22/02/2024 13:59:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4779 label Biography information for Taiwo Owatemi

1689324

registered interest
date	16/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department has made an estimate of the number of Cancer Alliances that are offering close family members of Lynch syndrome patients tests for that syndrome in accordance with NICE guidance.
tabling member constituency	Coventry North West
tabling member printed	Taiwo Owatemi
uin	14244
answer	answer is ministerial correction date of answer 22/02/2024 answer text <p>There are several different stages to testing for Lynch syndrome. We know from local audit data that, in line with the National Institute for Health and Care Excellence’s (NICE) guidelines, the mean proportion of colorectal cancer patients who receive an initial tumour test, immunohistochemistry or microsatellite instability, for Lynch syndrome is 94%, and for endometrial cancer is 95%. Although some funding has been provided to Cancer Alliances by NHS England to support this testing, we do not hold records of the number of tests carried out nationally.</p><p> </p><p>Where the result of the initial tumour test indicates Lynch syndrome, patients are referred for germline testing, which is commissioned directly by NHS England. Testing of family members of Lynch syndrome patients is not a direct Cancer Alliance responsibility. The 17 NHS Clinical Genetics Services are commissioned to provide predictive testing for family members when a diagnosis of Lynch Syndrome has been made in a first degree relative, in accordance with NICE guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 14243 question first answered 22/02/2024 13:59:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4779 label Biography information for Taiwo Owatemi

1688590

registered interest
date	08/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she plans to take to help increase the (a) stock of colonoscopy equipment, (b) number of colonoscopy facilities and (c) number of trained staff; and what other steps she plans to take to increase the use of colonoscopies in detecting bowel cancer.
tabling member constituency	Coventry North West
tabling member printed	Taiwo Owatemi
uin	13830
answer	answer is ministerial correction date of answer 19/02/2024 answer text <p>The Government is not currently planning to take steps to increase the stock of colonoscopy equipment. £2.3 billion was awarded at the Spending Review 2021 to transform diagnostic services over the next three years. Within this funding, NHS England is delivering an expected net increase uplift of 67 endoscopy rooms in acute trusts or in non-community diagnostic centre (CDC) developments. In CDCs, current plans are for 46 sites to be delivering endoscopies from March 2025, of which, 39 will deliver colonoscopies. This will help to support integrated care boards not currently meeting the optimal capacity of 3.5 rooms per 100,000 people over 50 years old, to do so.</p><p>NHS England will continue to deliver initiatives to train around 100 clinical endoscopists per annum to be capable of delivering colonoscopies and other gastrointestinal procedures. In addition to this NHS England is also training doctors, such as gastroenterologists, in the same procedures and continuing to develop, implement and improve immersive and rapid colonoscopy training through endoscopy academies.</p><p>As of October 2023, there are over 3,200 full-time equivalent doctors working in the specialty of gastroenterology within National Health Service trusts and other core organisations in England. This is over 100, or 4.3%, more than in 2022, over 500, or 20.1%, more than in 2019, and almost 1,400, or 75.2%, more than in 2010.</p><p>To improve bowel cancer diagnosis, the NHS has implemented timed cancer pathways for gastro-intestinal (GI) disease. This includes the implementation of Faecal Immunochemical Testing for those with symptoms in the lower GI, to prevent these patients from having unnecessary colonoscopies, freeing up capacity for these procedures and ensuring the most urgent symptomatic patients are seen more quickly.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/02/2024 09:34:00 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4779 label Biography information for Taiwo Owatemi

1688591

registered interest
date	08/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that people with Lynch Syndrome are (a) informed of their condition and (b) made aware of their increased risk of bowel cancer.
tabling member constituency	Coventry North West
tabling member printed	Taiwo Owatemi
uin	13831
answer	answer is ministerial correction date of answer 19/02/2024 answer text <p>NHS England, through the NHS Genomic Medicine Service, has launched a national transformation project to ensure more patients with Lynch syndrome are identified and benefit from regular check-ups, earlier interventions, and more targeted treatment, such as combinations of immunotherapy, chemotherapy and surgeries.</p><p>People aged between 25 and 75 years old identified as having Lynch Syndrome will be included in the surveillance arm of the National Health Service bowel cancer screening programme, and will be offered a colonoscopy every two years.</p><p>The national programme ensures all people diagnosed with bowel and endometrial are offered genomic testing, with a diagnosis for Lynch syndrome not only helping to guide more personalised cancer treatment but enabling their families and relatives to be offered testing too.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/02/2024 09:34:18 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4779 label Biography information for Taiwo Owatemi

1676286

registered interest
date	07/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she plans to reduce the minimum age for bowel screening to 50.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	5763
answer	answer is ministerial correction date of answer 12/12/2023 answer text <p>NHS England started the lowering of age for bowel cancer screening in April 2021. The following table shows the rollout plan for the bowel screening, keeping in mind that the timeline may differ slightly from region to region:</p><table><tbody><tr><td><p>Cohort age at first invitation</p></td><td><p>Year invitations start</p></td></tr><tr><td><p>56 years old</p></td><td><p>2021/22</p></td></tr><tr><td><p>58 years old</p></td><td><p>2022/23</p></td></tr><tr><td><p>54 years old</p></td><td><p>2023/24</p></td></tr><tr><td><p>50 and 52 years old</p></td><td><p>2024/25</p></td></tr></tbody></table><p> </p><p><strong> </strong></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 12/12/2023 16:32:03 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1675827

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 November to Question 881 on Bowel Cancer: Screening, what her planned timetable is for publishing a decision on lowering the screening age for bowel cancer from 60 to 50 years old.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	5575
answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>NHS England started the lowering of age for bowel cancer screening in April 2021. The following table shows the rollout plan for the bowel screening:</p><table><tbody><tr><td><p>Cohort age at first invitation</p></td><td><p>Year invitations start</p></td></tr><tr><td><p>Age 56</p></td><td><p>2021/22</p></td></tr><tr><td><p>Age 58</p></td><td><p>2022/23</p></td></tr><tr><td><p>Age 54</p></td><td><p>2023/24</p></td></tr><tr><td><p>Age 50 and 52</p></td><td><p>2024/25</p></td></tr></tbody></table><p> </p><p>Note: The timeline may differ slightly from region to region</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 11/12/2023 16:50:11 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4571 label Biography information for Gill Furniss